Why the study?
Treatment of resistant hypertension is challenging in patients with chronic kidney disease because medication choices may be limited, making device-based therapies attractive.
Device-based therapies offer potential alternative treatment options for resistant hypertension in patients with chronic kidney disease who have limited medication choices.
Answers are grounded in this paper and cite their sources.
Device therapies for resistant hypertension in CKD merit cautious exploration; leaves open their role pending randomized trials.
Treatment of resistant hypertension is a challenge, especially in patients who have chronic kidney disease. The choice of medications may be limited in this group, making the possibility of device-based therapies attractive. We explore 4 devices and procedures available to treat this vexing issue.
No takes yet. Share an insight, caveat, or question.
Gajulapalli et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: